InfuSystem Holdings, Inc. (INFU)

Market Cap	161.92M
Revenue (ttm)	109.91M
Net Income (ttm)	18,000
Shares Out	20.89M
EPS (ttm)	0.00
PE Ratio	8,995.60
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	29,132
Open	7.79
Previous Close	7.91
Day's Range	7.75 - 8.00
52-Week Range	6.10 - 10.88
Beta	1.20
Analysts	Buy
Price Target	15.47 (+99.61%)
Earnings Date	May 4, 2023

About INFU

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company a...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2005
• Employees: 394
• Stock Exchange: NYSEAMERICAN
• Ticker Symbol: INFU

Financial Performance

In 2022, INFU's revenue was $109.91 million, an increase of 7.36% compared to the previous year's $102.38 million. Earnings were $18,000, a decrease of -98.73%.

Analyst Forecast

According to 9 analysts, the average rating for INFU stock is "Buy." The 12-month stock price forecast is $15.47, which is an increase of 99.61% from the latest price.

Price Target

$15.47

(99.61% upside)

Analyst Consensus: Buy